India asks states to cancel licences for unauthorised fixed dose combinations

India's health ministry is clamping down on the country's burgeoning and increasingly confusing market for fixed dose combination drugs, limiting the tendency for manufacturers to formulate approved drugs in seemingly irrational combinations. The ministry is making it clear that the Drugs Controller General of India must have approved as 'new drugs' not only the components of combinations but also the combinations themselves.